What are the weight‑based dosages for first‑line anti‑tuberculosis therapy in children?

Pediatric TB Treatment Dosing

For drug-susceptible TB in children, use daily weight-based dosing: isoniazid 10-15 mg/kg (max 300 mg), rifampin 10-20 mg/kg (max 600 mg), pyrazinamide 30-40 mg/kg (max 2 g), and ethambutol 15-25 mg/kg (max 2.5 g) for the 2-month intensive phase, followed by isoniazid and rifampin for 4 months. 1

Standard First-Line Regimen

The current evidence strongly supports a 6-month treatment course consisting of:

Intensive Phase (2 months):

• Isoniazid: 10-15 mg/kg daily (maximum 300 mg) 1, 2
• Rifampin: 10-20 mg/kg daily (maximum 600 mg) 1, 2
• Pyrazinamide: 30-40 mg/kg daily (maximum 2 g) 1, 3
• Ethambutol: 15-25 mg/kg daily (maximum 2.5 g) 1, 4

Continuation Phase (4 months):

• Isoniazid: 10-15 mg/kg daily (maximum 300 mg) 1
• Rifampin: 10-20 mg/kg daily (maximum 600 mg) 1

Critical Dosing Considerations

Ethambutol use in young children: While ethambutol can be used safely in older children, use with caution in children younger than 5 years where visual acuity cannot be monitored 2. However, the AAP and most experts now include ethambutol as part of the intensive phase regimen for all children with TB due to rising drug resistance 5. The fourth drug (ethambutol) can be discontinued once drug susceptibility results confirm susceptibility to both isoniazid and rifampin 1.

Pyridoxine supplementation: Always give pyridoxine (vitamin B6) 25-50 mg daily to children at risk of neuropathy, including: pregnant adolescents, breastfeeding infants, HIV-infected children, those with diabetes, malnutrition, chronic renal failure, or infants whose mothers are receiving isoniazid 1, 5.

Weight-Band Dosing with Fixed-Dose Combinations

For children using WHO-recommended dispersible fixed-dose combination (FDC) tablets (rifampin/isoniazid/pyrazinamide 75/50/150 mg ± ethambutol 100 mg):

• 4.0-7.9 kg: 1 tablet daily
• 8.0-11.9 kg: 2 tablets daily
• 12.0-15.9 kg: 3 tablets daily
• 16.0-24.9 kg: 4 tablets daily
• ≥25 kg: Use adult dosing 6

Important caveat: Recent pharmacokinetic studies reveal that children in lower weight bands and those ≥25 kg receiving adult doses achieve lower drug exposures than adults, particularly for rifampin and ethambutol 6. Despite adherence to WHO guidelines, low rifampin and pyrazinamide exposures are frequent 7. This suggests higher doses may ultimately be needed, though current WHO recommendations remain the standard of care.

Intermittent Dosing (When Daily DOT Not Feasible)

If twice- or thrice-weekly dosing is necessary during the continuation phase:

Three times weekly:

• Isoniazid: 15 mg/kg (max 900 mg) 1
• Rifampin: 10 mg/kg (max 600 mg) 1

Twice weekly (only for non-immunosuppressed children):

• Isoniazid: 20-30 mg/kg (max 900 mg) 2
• Rifampin: 10-20 mg/kg (max 600 mg) 2

Critical warning: Twice-weekly regimens should NOT be used in severely immunosuppressed children (CD4 <15% or <100 cells/μL in children ≥6 years) as they may lead to rifamycin resistance 4.

Special Populations

HIV-infected children: Use the same dosing but avoid twice-weekly regimens in severely immunosuppressed patients. Initiate TB therapy 2-8 weeks before starting antiretrovirals in treatment-naïve children 4. Review and adjust antiretroviral regimens to minimize drug-drug interactions 4.

TB meningitis: Consider adding ethionamide 15-20 mg/kg daily (max 1 g) divided into 2-3 doses, and use adjunctive corticosteroids 4. Treatment duration should be 12 months for CNS disease 4.

Infants <6 months: The 10 mg/kg isoniazid dose is adequate and well-tolerated in this age group, with most achieving target adult levels 8.

Drug-Resistant TB

For isoniazid-resistant TB: Discontinue isoniazid and use rifampin + pyrazinamide + ethambutol (or a fluoroquinolone for extensive disease) for 6-12 months 4, 3.

For multidrug-resistant TB (resistance to both isoniazid and rifampin): Children require consultation with an expert and treatment for 18-24 months with at least 4-5 drugs including:

• A fluoroquinolone (levofloxacin 7.5-10 mg/kg daily) 3
• An injectable agent for 4-6 months
• Pyrazinamide 30-40 mg/kg 3
• Ethambutol 20-25 mg/kg 3
• Additional second-line agents based on susceptibility patterns 3

Monitoring and Administration

Directly observed therapy (DOT) should be the standard of care for all children with TB 4. Parents should not supervise DOT for their children 5. Daily dosing is preferred, though 5-days-a-week administration by DOT is an acceptable alternative 1.

Monitor for treatment response through clinical improvement and continued growth and development. Persistent hilar adenopathy on chest radiograph in an asymptomatic, improving child does not justify treatment extension, as it can take 1-2 years to resolve 5.